AU2075595A - Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same - Google Patents

Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same

Info

Publication number
AU2075595A
AU2075595A AU20755/95A AU2075595A AU2075595A AU 2075595 A AU2075595 A AU 2075595A AU 20755/95 A AU20755/95 A AU 20755/95A AU 2075595 A AU2075595 A AU 2075595A AU 2075595 A AU2075595 A AU 2075595A
Authority
AU
Australia
Prior art keywords
delipidated
preparation
same
injectable composition
polysaccharide compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20755/95A
Other languages
English (en)
Inventor
Hans Binz
Claude-Alain Cudennec
Jacques Durand
Alain Le Pape
Gerard Normier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU2075595A publication Critical patent/AU2075595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU20755/95A 1994-03-16 1995-03-15 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same Abandoned AU2075595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9403072 1994-03-16
FR9403072A FR2717483B1 (fr) 1994-03-16 1994-03-16 Préparation d'un composé polysaccharidique D25 délipidé et purifié et composition injectable en comportant.
PCT/FR1995/000311 WO1995025128A1 (fr) 1994-03-16 1995-03-15 Preparation d'un compose polysaccharidique d25 delipide et purifie et composition injectable en comportant

Publications (1)

Publication Number Publication Date
AU2075595A true AU2075595A (en) 1995-10-03

Family

ID=9461103

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20755/95A Abandoned AU2075595A (en) 1994-03-16 1995-03-15 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same

Country Status (6)

Country Link
EP (1) EP0750640A1 (de)
JP (1) JPH09512842A (de)
AU (1) AU2075595A (de)
CA (1) CA2185663A1 (de)
FR (1) FR2717483B1 (de)
WO (1) WO1995025128A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US4054645A (en) * 1976-08-24 1977-10-18 Minnesota Mining And Manufacturing Company Radiodiagnostic complexes employing fluorine-containing tin reducing agents
US4755381A (en) * 1986-03-27 1988-07-05 Swiss Serum And Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
FR2659351B1 (fr) * 1990-03-08 1994-12-02 Pf Medicament Compose polysaccharidique delipide, procede de preparation, compositions en comprenant.

Also Published As

Publication number Publication date
JPH09512842A (ja) 1997-12-22
FR2717483B1 (fr) 1996-06-07
FR2717483A1 (fr) 1995-09-22
WO1995025128A1 (fr) 1995-09-21
EP0750640A1 (de) 1997-01-02
CA2185663A1 (fr) 1995-09-21

Similar Documents

Publication Publication Date Title
AU2616695A (en) Synergistic composition
AU4027195A (en) Water-in-oil-in-water compositions
AU3686495A (en) Benzothiophene compounds, compositions, and methods
AU3137295A (en) Glass compositions
AU5136998A (en) Medicinal composition
AU5794094A (en) Tricritical point composition
AU2215995A (en) Freeze-dried compositions comprising rna
AU6361294A (en) Taxol-based compositions with enhanced bioactivity
AU3794595A (en) Pharmaceutical, orally applicable composition
AU3308195A (en) Antihypertriglyceridemic composition
AU6105896A (en) Purified galactomannan as an improved pharmaceutical excipie nt
AU6856094A (en) Oxadiazole derivative and medicinal composition thereof
AU5317598A (en) Novel pharmaceutical compositions
AU7957794A (en) Anti-allergic, anti-inflammatory compounds, compositions and uses
AU2344095A (en) Benzamide derivative, compositions containing said derivative and use thereof
AU3694095A (en) Gas purifying composition
AU2531295A (en) Pharmaceutical composition
AU7768994A (en) Stable lyophilized thiotepa composition
AU2310395A (en) Topical retinal-based composition
AU3460897A (en) Medicinal compositions
AU2075595A (en) Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same
EP0688822A3 (de) Degradierbare Mischungszusammensetzung
AU1427895A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU7686394A (en) Rectally-administered, epileptic-seizure-inhibiting composition